DEPLOYDatabase

Robot model

ANOVO

surgicalcommercialby Momentis Surgical

Miniaturized robotic surgical system for transvaginal benign gynecological procedures and general surgery.

Track ANOVO
Manufacturer
Momentis Surgical
Form factor
surgical
Maturity
commercial
Lifecycle
active
Deployments
3

The verified answer

As of Sep 2026, DEPLOY verifies ANOVO, a surgical by Momentis Surgical (commercial): 3 verified deployments on record. 1 source back the record.

Regulatory status1 FDA 510(k) clearance

ANOVO holds 1 FDA 510(k) clearance, per the DEPLOY registry.

See all 1 filings

Overview

Miniaturized robotic surgical system for transvaginal benign gynecological procedures and general surgery. Features 2-armed, 360-degree articulating robotic instruments designed to mimic human arms, with haptic feedback and dual-mode articulation in the second generation. FDA 510(k) cleared for gynecological and general surgery indications.

Verified vs. claimed

Maturity stage
commercial(Commercially deployed with revenue-generating operations.)
Sources on file
View all sources →

Key facts

Form factor

Surgical robot (miniaturized, 2-armed)

Articulation

360-degree, dual-mode

Haptic feedback

Second generation

FDA 510(k)

Cleared — gynecology + general surgery

Deployments

HCA Florida Northwest, Medical City Plano, Lee Health

Data & sources

Web sources

1

1 source backing this record.View all →

Pricing

No verified price is on record for ANOVO. Physical-AI systems are often sold through enterprise contracts or operated as a service rather than at a public list price.

How DEPLOY tracks pricing

Deployments (3)

Free to use on your site, with a link back to DEPLOY.

ANOVO on the deployment map

View the global map

Where ANOVO is verified operating. Explore the deployment map by place and type.

Free to use on your site, with a link back to DEPLOY.

Recent activity

Every change to this record is dated, sourced, and independently verified where marked.

Full change history →

Regulatory filings (1)

Safety record

1 incident on record (1 moderate). Most recent: Jul 2026.

moderate
1

Most recent: Jul 2026

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Incidents affecting ANOVO (1)

Includes incidents linked directly to this model or to deployments of it. Retracted incidents are excluded from this view but remain reachable at their canonical URLs.

Sources (1)

  1. https://www.prnewswire.com/news-releases/momentis-surgical-receives-fda-510k-clearance-for-second-generation-anovo-robotic-platform-introducing-haptic-feedback-and-dual-mode-articulation-302301074.html

Common questions

What is ANOVO?
Miniaturized robotic surgical system for transvaginal benign gynecological procedures and general surgery. Features 2-armed, 360-degree articulating robotic instruments designed to mimic human arms, with haptic feedback and dual-mode articulation in the second generation. FDA 510(k) cleared for gynecological and general surgery indications.
How much does ANOVO cost?
ANOVO's price is not publicly disclosed. DEPLOY has no verified price on record for ANOVO from Momentis Surgical. Physical-AI systems like this are often sold through enterprise contracts or operated as a service rather than at a public list price; check the manufacturer for the latest.
Is ANOVO actually deployed in the real world?
Yes. ANOVO is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.
Who makes ANOVO?
ANOVO is made by Momentis Surgical, based in Yokne'am Illit, Israel, founded in 2012.
Where is ANOVO deployed?
3 verified deployments of ANOVO are on the DEPLOY registry, including at Fort Myers, Florida, USA, Plano, Texas, USA, Margate, Florida, USA.
Can you buy ANOVO?
ANOVO is in commercial deployment and is sold to operators; contact the manufacturer to buy, and see the pricing section for any recorded price.
Is ANOVO FDA cleared?
ANOVO has 1 regulatory record on the DEPLOY registry: FDA 510(k) clearance, cleared. See the Regulatory filings section for each agency source.
What are alternatives to ANOVO?
On the DEPLOY registry, comparable surgical robots to ANOVO include da Vinci (and Ion), Edge Multi-Port Surgical Robot, Edison Histotripsy System, Stryker Mako SmartRobotics.
How does ANOVO compare to da Vinci (and Ion)?
ANOVO and da Vinci (and Ion) (Intuitive Surgical · 15 deployments) are both surgical robots on the DEPLOY registry. ANOVO has 3 verified deployments on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.
Is ANOVO a top surgical?
On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, ANOVO ranks in roughly the top 34% of surgical models tracked by the registry.
What is ANOVO's maturity stage?
ANOVO is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.
Is ANOVO safe?
ANOVO has 1 active incident on record in the DEPLOY registry. 1 incident on record (1 moderate). Most recent: Jul 2026. Retracted incidents are excluded from this count.
Methodology: Verified · 1 source (no primary) · last reviewed 2026-08-09

Verification posture

Verified

Low confidence

Review state

Stable

Last reviewed 2026-08-09

Maturity + lifecycle

Maturity stage: commercial

Lifecycle: active

Architectural position

Cohort: surgical

Sources by quality tier

1
unclassified
Unclassified source

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for ANOVO.

Recent coverage

ANOVO in third-party press

Regulatory roundup – July 2026 - Today's Medical Developments

Jul 31, 2026

FDA clears Momentis Surgical’s multiport surgical robot - MassDevice

Jul 23, 2026

FDA Clears Momentis Surgical's Anovo® System for Multiport Surgery, Making It the First Robotic Platform to Support Three Surgical Approaches - PR Newswire

Jul 23, 2026